Clinical Trials Directory

Trials / Completed

CompletedNCT01699074

Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes

Acute Dose Response Effects of Korean White Ginseng (Panax Ginseng C.A. Meyer) on Cardiovascular Disease Risk Factors in Individuals With Metabolic Syndrome or Type 2 Diabetes

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study is a Phase-I like double blind randomized placebo controlled crossover design trial. The objective is to assess the dose response relationship on glycemic and vascular effects of an acutely administered Korean White Ginseng (KWG)(Panax C.A. Meyer) in individuals with metabolic syndrome or type 2 diabetes . Twenty seven subjects with Type 2 Diabetes (Key inclusion criteria: HbA1c ≤8.5%)or metabolic syndrome (Key inclusion criteria: as defined by The US National Cholesterol Education Program Adult Treatment Panel III)will be recruited for the study.

Detailed description

This study hypothesizes that KWG will dose dependently lower postprandial area under the curve compared to negative control, as well as will dose dependently decrease postprandial glycemia. It also assumes that use of KWG will dose dependently decrease aortic and brachial blood pressure, aortic augmentation index, and mean arterial pressure, and improve left ventricular ejection duration(ED) and subendocardial viability ratio (SEVR) compared to control. Finally, it expects to notice an effect on subjective satiety levels and have no significant adverse effects compared to control.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT1 gram of White Korean Ginseng1 gram of White Korean Ginseng
DIETARY_SUPPLEMENT3 grams of White Korean Ginseng3 grams of White Korean Ginseng
DIETARY_SUPPLEMENT6 grams of White Korean Ginseng6 grams of White Korean Ginseng
DIETARY_SUPPLEMENT3 grams of Wheat Bran Control3 grams of Wheat Bran Control
DIETARY_SUPPLEMENT500mg of Korean Red Ginseng500mg of Korean Red Ginseng

Timeline

Start date
2013-05-01
Primary completion
2013-09-01
Completion
2014-01-01
First posted
2012-10-03
Last updated
2014-04-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01699074. Inclusion in this directory is not an endorsement.